Search results
Results will auto-populate based on filter selection.
Found 632 result(s)
Each year, we are required under the Workplace Safety and Insurance Act to conduct a value-for-money audit. The latest audit focused on the dispute resolution, appeals and…
On this page: 1. Introduction 1.1. Background 2. Occupational disease legislative and policy scheme…
The Drug Advisory Committee was established in 2007 to guide WSIB on which drugs to include in our drug benefit plan as well as the medical conditions and criteria needed for…
Each year, we are required under the Workplace Safety and Insurance Act (WSIA) to have an external firm review the cost, efficiency, and effectiveness of one of our programs…
Indication(s)The treatment of schizophrenia and related psychotic disorders, manic or mixed episodes in bipolar I disorder, and for use as an adjunct to antidepressants for…
Indication(s)Benzodiazepines are indicated in a treatment of a variety of disorders (depending on their pharmacokinetic profile and evidence), including anxiety disorder,…
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A Indication(s) OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Burpenorphine transdermal patch - butrans® and burprenorphine buccal soluble film belbuca®Indication(s)The management of pain severe enough to require daily, continuous, long…
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
Indication(s)Compounded topical analgesics have not been approved by Health Canada and thus have no official indication for the topical treatment of pain.Formulary statusThe…
Corticosteroid injections in musculoskeletal conditions Indications/Clinical uses Treatment of acute and chronic musculoskeletal conditions including neck and upper…
Indication(s)Symptomatic relief of major depressive disorder (MDD).DAC recommendationThe Drug Advisory Committee (DAC) has recommended that desvenlafaxine not be listed on…
Indication (s)Treatment of symptoms associated with osteoarthritis of the knee (duration of treatment not to exceed 3 months).DAC recommendationThe Drug Advisory Committee (…
Indication(s)Symptomatic relief of major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain associated with diabetic peripheral neuropathy (DPN…
Indication(s)Treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and obsessive compulsive disorder (OCD).Formulary statusThe Drug Advisory…
Indication(s)Clinical management of occupational exposure to HIV.Formulary statusThe Drug Advisory Committee (DAC) recommended antiretroviral medications emtricitabine/…
Hypnotics: zopiclone, zolpidem, trazodone and tryptophanIndication(s)Zopiclone and sublingual zolpidem (oral disintegrating tablet, ODT- sublinox®): GABA agonists for short-…
Indication(s)The management of severe nausea and vomiting associated with cancer chemotherapy.Formulary statusThe Drug Advisory Committee (DAC) recommended that generic…
Indication(s)The relief of moderate to severe pain in adults who require continuous opioid analgesia for several days or more. The naloxone component is indicated for the…
Indication(s)Treatment of schizophrenia.DAC recommendationThe Drug Advisory Committee (DAC) recommended that paliperidone not be listed on any WSIB formularies as there are…
Indication(s)Piroxicam is used to treat pain and a variety of inflammatory conditions.DAC recommendationThe Drug Advisory Committee (DAC) has recommended that piroxicam be…
Indication(s)Treatment of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury and pain associated with fibromyalgia.…